Marshall Wace, LLP Pacific Biosciences Of California, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 2,121,920 shares of PACB stock, worth $3.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,121,920

Previous 1,611,300 31.69%

Holding current value

$3.88 Million

Previous $2.21 Million 63.43%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.2 - $2.17 $612,744 - $1.11 Million	510,620 Added 31.69%	2,121,920 $3.61 Million
Q2 2024 Aug 14, 2024	BUY	$1.36 - $3.65 $1.52 Million - $4.08 Million	1,117,966 Added 226.61%	1,611,300 $2.21 Million
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $1.23 Million - $3.35 Million	349,246 Added 242.38%	493,334 $1.85 Million
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $2.06 Million - $3.57 Million	-344,380 Reduced 70.5%	144,088 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $4.02 Million - $6.8 Million	488,468 New	488,468 $4.08 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $12.02 $504,984 - $764,472	-63,600 Reduced 84.69%	11,500 $133,000
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $82,215 - $162,400	-14,500 Reduced 16.18%	75,100 $614,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $352,128 - $767,872	89,600 New	89,600 $520,000
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $1.53 Million - $4.16 Million	-146,005 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.61 - $9.87 $8,144 - $22,266	-2,256 Reduced 1.52%	146,005 $1.44 Million
Q2 2020 Aug 13, 2020	SELL	$2.65 - $4.03 $101,643 - $154,574	-38,356 Reduced 20.55%	148,261 $512,000
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $238,423 - $531,402	-101,027 Reduced 35.12%	186,617 $571,000
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $1.75 Million - $2.12 Million	-380,493 Reduced 56.95%	287,644 $1.48 Million
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $1.98 Million - $2.44 Million	396,180 Added 145.68%	668,137 $3.45 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $4.06 Million - $5.08 Million	-685,257 Reduced 71.59%	271,957 $1.65 Million
Q1 2019 May 14, 2019	BUY	$6.8 - $7.4 $2.29 Million - $2.5 Million	337,213 Added 54.39%	957,214 $6.92 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $2.47 Million - $4.85 Million	620,001 New	620,001 $4.59 Million

Others Institutions Holding PACB

# of Institutions

255

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $411M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Pacific Biosciences Of California, Inc. Transaction History